Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.

Autor: Lin, Shaoyan1 (AUTHOR), Zhou, Huaqiang2 (AUTHOR), Chen, Gang2 (AUTHOR), Xue, Jinhui1 (AUTHOR), Liu, Qianwen1 (AUTHOR), Li, Jianing1 (AUTHOR), Yang, Yanhua1 (AUTHOR), Zhao, Yuanyuan2 (AUTHOR), Bao, Hua3 (AUTHOR), Huang, Yan2 (AUTHOR) huangyan@sysucc.org.cn, Ma, Yuxiang1 (AUTHOR) mayx@sysucc.org.cn, Zhao, Hongyun1 (AUTHOR) zhaohy@sysucc.org.cn
Zdroj: BMC Cancer. 7/3/2024, Vol. 24 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje